On Assignment (ASGN) has been rated by 6 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $47 and the lowest price target forecast is $41. The average forecast of all the analysts is $43.83 and the expected standard deviation is $2.14.
On Assignment (ASGN) : Zacks Investment Research ranks On Assignment (ASGN) as 3, which is a Hold recommendation. 7 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 8 research analysts is 1.25, which indicates as a Strong Buy.
Also, Deutsche Bank initiates coverage on On Assignment (NYSE:ASGN). The rating major has initiated the coverage with buy rating on the shares. The rating by the firm was issued on August 18, 2016.
On Assignment (NYSE:ASGN): The stock opened at $37.68 on Thursday but the bulls could not build on the opening and the stock topped out at $38.08 for the day. The stock traded down to $37.34 during the day, due to lack of any buying support eventually closed down at $37.67 with a loss of -0.11% for the day. The stock had closed at $37.71 on the previous day. The total traded volume was 416,347 shares.
On Assignment, Inc. is a global provider of professionals in the information technology (IT), engineering and life sciences sectors. The Company matches people into positions for contract, contract-to-hire and direct hire assignments. Its operating segments include Apex, Oxford and Life Sciences Europe. The Apex Segment provides information technology and scientific staffing professionals for contract, contract-to-hire and permanent placement positions. The Oxford Segment provides contract and direct placement services of information technology and engineering professionals in specialized information technology, software and hardware engineering, and mechanical, electrical, validation and telecommunications engineering fields. The Life Sciences Europe Segment provides locally-based contract life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, automotive, educational and environmental industries.